REED ELIZABETH E (SVP, GC & Corporate Secretary) sold 8.7% of their position (10K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $278.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/19/2026ACC: 0001283303-26-000005
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
-10K
Net shares
Net seller
$278.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10K
Price / share
$19.08
Trade value
$190.80K
% of position
9.5%
2/17/2026
105.21K→115.21K
Common Stock
Direct
Shares
−5.68K
Price / share
$27.50
Trade value
$156.20K
% of position
4.9%
2/17/2026
115.21K→109.53K
Common Stock
Direct
Shares
−4.32K
Price / share
$28.26
Trade value
$122.12K
% of position
3.9%
2/17/2026
109.53K→105.21K
Total
Net shares
+0.00
Net value
-$87.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +10K | $19.08 | $190.80K | 9.5% | 105.21K | 115.21K |
| Common Stock Direct | 2/17/2026 | S · Sale | −5.68K | $27.50 | $156.20K | 4.9% | 115.21K | 109.53K |
| Common Stock Direct | 2/17/2026 | S · Sale | −4.32K | $28.26 | $122.12K | 3.9% | 109.53K | 105.21K |
| Total | +0.00 | -$87.52K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
19.08
Held after
20K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock10K shares | 2/17/2026 | M · Option Exercise | −10K | 19.08 | — | 20K |